StocksFundsScreenerSectorsWatchlists
HUM

HUM - Humana Inc Stock Price, Fair Value and News

312.58USD-3.71 (-1.17%)Market Closed

Market Summary

HUM
USD312.58-3.71
Market Closed
-1.17%

HUM Stock Price

View Fullscreen

HUM RSI Chart

HUM Valuation

Market Cap

37.7B

Price/Earnings (Trailing)

15.15

Price/Sales (Trailing)

0.35

EV/EBITDA

9.29

Price/Free Cashflow

12.67

HUM Price/Sales (Trailing)

HUM Profitability

EBT Margin

3.18%

Return on Equity

15.31%

Return on Assets

5.29%

Free Cashflow Yield

7.89%

HUM Fundamentals

HUM Revenue

Revenue (TTM)

106.4B

Rev. Growth (Yr)

17.93%

Rev. Growth (Qtr)

0.15%

HUM Earnings

Earnings (TTM)

2.5B

Earnings Growth (Yr)

-3.5K%

Earnings Growth (Qtr)

-165.02%

Breaking Down HUM Revenue

Last 7 days

-0.2%

Last 30 days

-9.4%

Last 90 days

-28.7%

Trailing 12 Months

-41.6%

How does HUM drawdown profile look like?

HUM Financial Health

Current Ratio

1.59

Debt/Equity

0.63

Debt/Cashflow

0.39

HUM Investor Care

Dividend Yield

0.41%

Dividend/Share (TTM)

1.49

Buy Backs (1Y)

3.46%

Diluted EPS (TTM)

19.99

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202395.6B98.7B102.4B106.4B
202286.4B89.4B91.5B92.9B
202175.9B77.5B78.1B83.1B
202067.7B70.6B74.4B74.2B
201958.7B60.7B62.8B64.9B
201854.3B55.0B55.9B56.9B
201754.3B53.9B53.5B53.8B
201654.3B54.5B54.9B54.4B
201550.6B52.1B53.3B54.3B
201442.5B44.4B46.4B48.5B
201339.4B40.0B40.7B41.3B
201237.9B38.3B38.6B39.1B
201134.4B35.1B36.1B36.8B
201031.5B32.2B32.9B33.6B
200929.5B29.9B30.5B30.7B
2008026.4B27.6B28.8B
200700025.3B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Humana Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 22, 2024
ventura joseph c
acquired
-
-
3,411
chief legal officer
Feb 22, 2024
fleming william kevin
sold (taxes)
-448,845
366
-1,226
chief corporate aff. officer
Feb 22, 2024
huval timothy s.
acquired
-
-
3,712
chief administrative officer
Feb 22, 2024
renaudin george ii
sold (taxes)
-101,777
366
-278
president, medicare & medicaid
Feb 22, 2024
broussard bruce d
sold (taxes)
-3,102,010
366
-8,473
chief executive officer
Feb 22, 2024
agrawal vishal
acquired
-
-
3,010
chief strat & corp dev officer
Feb 22, 2024
broussard bruce d
acquired
-
-
22,572
chief executive officer
Feb 22, 2024
ventura joseph c
sold (taxes)
-422,119
366
-1,153
chief legal officer
Feb 22, 2024
renaudin george ii
acquired
-
-
1,104
president, medicare & medicaid
Feb 22, 2024
diamond susan m
sold (taxes)
-411,868
366
-1,125
chief financial officer

1–10 of 50

Which funds bought or sold HUM recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 11, 2024
Radnor Capital Management, LLC
sold off
-100
-277,000
-
-%
Apr 11, 2024
Gulf International Bank (UK) Ltd
added
0.47
-1,124,000
3,575,000
0.09%
Apr 11, 2024
Cooper Financial Group
reduced
-46.98
-639,963
429,170
0.07%
Apr 11, 2024
Fortitude Family Office, LLC
reduced
-64.29
-9,352
3,467
-%
Apr 11, 2024
Pflug Koory, LLC
unchanged
-
-5,555
17,336
0.01%
Apr 11, 2024
SALEM INVESTMENT COUNSELORS INC
unchanged
-
-2,111
6,605
-%
Apr 11, 2024
CENTRAL BANK & TRUST CO
reduced
-7.13
-540,938
1,282,480
0.18%
Apr 11, 2024
TEALWOOD ASSET MANAGEMENT INC
added
39.12
75,000
1,465,000
0.66%
Apr 11, 2024
City State Bank
new
-
153,000
153,000
0.07%
Apr 11, 2024
Ballentine Partners, LLC
reduced
-41.8
-619,829
488,529
0.01%

1–10 of 48

Are Funds Buying or Selling HUM?

Are funds buying HUM calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own HUM
No. of Funds

Unveiling Humana Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 16, 2024
price t rowe associates inc /md/
3.2%
3,903,291
SC 13G/A
Feb 14, 2024
price t rowe associates inc /md/
3.2%
3,903,291
SC 13G/A
Feb 13, 2024
vanguard group inc
9.07%
11,171,000
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Feb 08, 2024
wellington management group llp
4.36%
5,363,011
SC 13G/A
Feb 07, 2024
blackrock inc.
9.1%
11,248,135
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
6.0%
7,623,150
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
8.97%
11,357,974
SC 13G/A
Feb 06, 2023
wellington management group llp
6.01%
7,611,181
SC 13G

Recent SEC filings of Humana Inc

View All Filings
Date Filed Form Type Document
Apr 01, 2024
4
Insider Trading
Apr 01, 2024
4
Insider Trading
Apr 01, 2024
4
Insider Trading
Apr 01, 2024
4
Insider Trading
Mar 14, 2024
PX14A6G
PX14A6G
Mar 13, 2024
8-K
Current Report
Mar 12, 2024
424B5
Prospectus Filed
Mar 11, 2024
424B5
Prospectus Filed
Mar 11, 2024
FWP
Prospectus Filed
Mar 08, 2024
ARS
ARS

Peers (Alternatives to Humana Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
404.6B
371.6B
-10.06% -16.60%
18.08
1.09
14.64% 11.24%
102.3B
195.3B
0.36% 32.66%
19.05
0.52
8.17% -20.79%
86.4B
357.8B
-8.56% -8.98%
10.34
0.24
10.95% 93.52%
85.4B
65.0B
0.28% 18.07%
16.29
1.31
7.86% -7.11%
37.8B
154.0B
-7.79% 1.99%
14
0.25
6.54% 124.79%
11.6B
14.3B
-4.37% 22.44%
16.11
0.81
6.59% 6.24%
11.4B
12.1B
-5.66% 54.55%
16.54
0.94
4.57% 23.40%
MID-CAP
9.4B
2.3B
-4.31% 9.94%
34.32
4.13
6.06% 9.17%
6.8B
2.9B
-6.65% -2.97%
-311.58
2.31
12.20% -107.93%
2.3B
1.4B
-0.51% 1.54%
37.23
1.63
21.19% 34.42%
2.1B
3.8B
-4.61% -35.19%
10.19
0.57
-27.73% -52.50%
SMALL-CAP
1.6B
1.1B
-1.23% -12.42%
25.41
1.5
11.31% 35.83%
1.2B
3.0B
4.69% 55.53%
-6.48
0.41
6.74% 20.73%
51.1M
-
-15.28% -9.77%
-3.49
-
- -12.94%
18.5M
21.3M
10.98% 5.02%
34.8
0.87
8.00% -62.25%

Humana Inc News

Latest updates
Defense World106 minutes ago
MarketBeat39 hours ago

Humana Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue0.1%26,46226,42326,74726,74222,43922,79923,66223,97021,05420,69720,64520,66816,09320,07519,08318,93516,29516,24116,24516,10714,168
  S&GA Expenses17.0%3,8273,2713,1112,9793,5513,0613,1732,8863,3952,6032,1162,0073,0682,5132,3542,1172,1291,8891,7031,6602,115
EBITDA Margin-12.9%0.04*0.05*0.06*0.06*0.05*0.05*0.06*0.05*0.05*0.05*0.05*0.08*0.07*0.09*0.08*0.06*0.06*0.06*0.07*--
Interest Expenses28.1%14611412011310810210190.0091.0088.0079.0068.0072.0075.0076.0060.0058.0062.0060.0062.0059.00
Income Taxes-129.3%-75.00256296359-58.00107427286-51.00120183233-17845078325279.0020030118383.00
Earnings Before Taxes-153.8%-5911,0981,2621,614-71.001,2971,1221,220-60.001,6367381,040-4581,7552,5867175938881,229746436
EBT Margin-16.6%0.03*0.04*0.04*0.04*0.04*0.04*0.05*0.04*0.04*0.04*0.04*0.06*0.06*0.08*0.07*0.05*0.05*0.05*0.05*--
Net Income-165.0%-5418329591,239-15.001,195696930-14.001,531588828-2741,3401,828473512689940566355
Net Income Margin-20.6%0.02*0.03*0.04*0.03*0.03*0.03*0.04*0.04*0.04*0.03*0.03*0.05*0.05*0.06*0.05*0.04*0.04*0.04*0.04*--
Free Cashflow-828.6%-7,4171,0182,9126,464-5,3858,1656807.00-4672,50931.00-1,127-13.001,5652,8412822822,2321,277--
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-15.8%47,06555,90556,45554,77643,05550,76546,82046,30844,35845,32038,07037,41534,96938,47738,45534,63329,07429,18028,91328,34925,413
  Current Assets-21.6%29,98638,25338,75937,53226,18333,71127,21726,84024,89325,81525,79025,52623,64127,03127,86824,55119,88820,32420,16019,67316,948
    Cash Equivalents-69.0%4,69415,14816,21413,7355,06113,5585,2204,8643,3944,3043,3783,8774,6737,9857,1636,0544,0545,5274,7783,8772,343
  Net PPE-9.3%3,0303,3423,3093,2343,2213,2183,1213,1893,0732,8982,6902,5072,3712,2282,1182,0231,9551,8641,7961,7541,735
  Goodwill0.1%9,5509,5409,5399,3209,1429,0968,91111,13911,09210,8064,9144,6024,4474,4434,4434,4433,9283,9223,9223,8973,897
Liabilities-21.0%30,74738,90139,56438,14227,68534,44831,31030,96628,25529,03823,22723,22521,24122,70924,03922,27817,03717,57917,04117,50815,252
  Current Liabilities-32.2%18,87227,82328,27926,94217,17825,05117,83917,53215,33115,02715,05115,30013,39414,90516,45514,83010,92911,10611,53911,92710,077
  Short Term Borrowings---------------------1,694
  Long Term Debt7.7%10,2139,4839,7229,7439,0347,79811,29011,28510,54111,4666,0636,0626,0606,0596,0586,0574,9675,3654,3774,3764,375
    LT Debt, Non Current7.7%10,2139,4839,7229,7439,0347,79811,29011,28510,54111,4666,0636,0626,0606,0596,0586,0574,9675,3654,3774,3764,375
Shareholder's Equity-4.1%16,26216,94916,89116,63415,31116,31715,51015,34216,10316,28214,84314,19013,72815,76814,41612,35512,03711,60111,87210,84110,161
  Retained Earnings-2.3%27,54028,19127,46826,61925,49225,60624,51123,91523,08623,19121,75121,25220,51720,87219,61617,87117,48317,04516,42915,56315,072
  Additional Paid-In Capital-0.5%3,3463,3623,3133,2623,2463,2343,1533,1033,0823,0643,0182,7122,7052,9402,8982,8572,8202,6082,7632,7222,535
Shares Outstanding-100.0%-123124125-127127126-129129129-132132132-132135135-
Minority Interest1.8%56.0055.0057.0057.0059.0063.0020.0023.0023.0022.00-----------
Float---55,097---59,158---56,778---50,712---35,479--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-669.8%-7,1341,2523,1766,687-5,1278,453959302-96.002,835360-8372831,8153,0674745122,4421,434896-333
  Share Based Compensation-37.7%33.0053.0051.0038.0043.0080.0050.0043.0048.0048.0045.0039.0052.0047.0046.0036.0044.0043.0043.0033.0032.00
Cashflow From Investing-50.8%-882-585-733-1,292-1,0121,676-1,022-648-102-4,251-715-1,488-55.00-148-1,652-1,210-801-566-56.00145-447
Cashflow From Financing-40.7%-2,438-1,73336.003,279-2,358-1,7914191,816-7122,342-1441,529-3,540-845-3062,736-1,184-1,127-477493-1,019
  Dividend Payments1.8%11110911110010110010091.0091.0090.0090.0083.0084.0083.0083.0073.0075.0074.0074.0068.0070.00
  Buy Backs50.7%57137952994.001,0644.004.001,02443.003.003.0030.001,7905.008.0017.0060.001,000-10.00796

HUM Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
ServicesHealth Care [Member]Health Care [Member]Health Care [Member]
Revenues:   
Premiums$ 101,272$ 87,712$ 79,822
Services4,0334,7763,055
Investment income1,069382187
Total revenues106,37492,87083,064
Operating expenses:   
Benefits88,39475,69069,199
Operating costs13,18812,67110,121
Depreciation and amortization779709596
Total operating expenses102,36189,07079,916
Income from operations4,0133,8003,148
Gain on sale of Gentiva Hospice0(237)0
Interest expense493401326
Other expense (income), net13768(532)
Income before income taxes and equity in net earnings3,3833,5683,354
Provision for income taxes836762485
Equity in net (losses) earnings(63)(4)65
Net income2,4842,8022,934
Net loss (income) attributable to noncontrolling interests54(1)
Net income attributable to Humana$ 2,489$ 2,806$ 2,933
Basic earnings per common share (in dollars per share)$ 20.09$ 22.20$ 22.79
Diluted earnings per common share (in dollars per share)$ 20.00$ 22.08$ 22.67

HUM Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 4,694$ 5,061
Investment securities16,62613,881
Receivables, net of allowances of $88 in 2023 and $70 in 20222,0351,674
Other current assets6,6315,567
Total current assets29,98626,183
Property and equipment, net3,0303,221
Long-term investment securities382380
Goodwill9,5509,142
Equity method investments740749
Other long-term assets3,3773,380
Total assets47,06543,055
Current liabilities:  
Benefits payable10,2419,264
Trade accounts payable and accrued expenses6,5695,238
Book overdraft353298
Unearned revenues266286
Short-term debt1,4432,092
Total current liabilities18,87217,178
Long-term debt10,2139,034
Other long-term liabilities1,6621,473
Total liabilities30,74727,685
Commitments and contingencies (Note 17)
Stockholders' Equity:  
Preferred stock, $1 par; 10,000,000 shares authorized; none issued00
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,690,082 shares issued at December 31, 2023 and 198,666,598 shares issued at December 31, 20223333
Capital in excess of par value3,3463,246
Retained earnings27,54025,492
Accumulated other comprehensive loss(999)(1,304)
Treasury stock, at cost, 76,465,862 shares at December 31, 2023 and 73,691,955 shares at December 31, 2022(13,658)(12,156)
Total stockholders' equity16,26215,311
Noncontrolling interests5659
Total equity16,31815,370
Total liabilities and equity$ 47,065$ 43,055
HUM
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
 CEO
 WEBSITEhumana.com
 INDUSTRYHealthcare Plans
 EMPLOYEES65535

Humana Inc Frequently Asked Questions


What is the ticker symbol for Humana Inc? What does HUM stand for in stocks?

HUM is the stock ticker symbol of Humana Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Humana Inc (HUM)?

As of Fri Apr 12 2024, market cap of Humana Inc is 37.71 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HUM stock?

You can check HUM's fair value in chart for subscribers.

What is the fair value of HUM stock?

You can check HUM's fair value in chart for subscribers. The fair value of Humana Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Humana Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HUM so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Humana Inc a good stock to buy?

The fair value guage provides a quick view whether HUM is over valued or under valued. Whether Humana Inc is cheap or expensive depends on the assumptions which impact Humana Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HUM.

What is Humana Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, HUM's PE ratio (Price to Earnings) is 15.15 and Price to Sales (PS) ratio is 0.35. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HUM PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Humana Inc's stock?

In the past 10 years, Humana Inc has provided 0.117 (multiply by 100 for percentage) rate of return.